Replies to post #16029 on FDA Plays

[io_io]

What are everyone's thoughts on short term PT?

Well its one instance where both sides will want to partner. There is a patent cliff in these cardio-health drugs, while on the AMRN side they would like someone to conduct the Outcomes study. Basically it will be of question of price. But any deal is probably several months away, as negotiations take time.